Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Corteva $500 million senior notes offering
The investment-grade notes are due 2032
FirstCash £299 million term loan
We are advising the lead arranger, initial lender and administrative agent on the financing
Orbia $1.1 billion notes offering
We advised Orbia on the investment-grade debt offering
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
Middlesex Water $110 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Bank of America $5 billion floating-rate and fixed-to-floating-rate notes
The investment-grade debt offering is based on the Secured Overnight Financing Rate
Bank of America $3 billion preferred stock offering
The company issued depositary shares representing interests in fixed-rate reset non-cumulative preferred stock
Auna $62.1 million senior secured notes offering
We advised Auna on the offering
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055